B. Riley Predicts Aspen Aerogels FY2024 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - Equities research analysts at B. Riley issued their FY2024 EPS estimates for shares of Aspen Aerogels in a research note issued on Monday, January 6th. B. Riley analyst R. Pfingst forecasts that the construction company will post earnings per share of $0.16 for the year. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels' Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.54 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $1.33 EPS.

ASPN has been the topic of several other research reports. Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, November 13th. Roth Mkm decreased their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research report on Friday, November 8th. Barclays dropped their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 12th. Finally, HC Wainwright reiterated a "buy" rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $30.00.

Aspen Aerogels Stock Performance

Shares of ASPN traded down $0.12 during mid-day trading on Thursday, reaching $13.18. 1,385,737 shares of the company's stock traded hands, compared to its average volume of 1,623,833. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The business's 50-day moving average price is $14.05 and its 200-day moving average price is $20.73. The stock has a market capitalization of $1.08 billion, a P/E ratio of 1,319.32 and a beta of 2.14. Aspen Aerogels has a 12 month low of $10.75 and a 12 month high of $33.15.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp boosted its holdings in shares of Aspen Aerogels by 26.2% in the second quarter. Bank of New York Mellon Corp now owns 226,666 shares of the construction company's stock worth $5,406,000 after buying an additional 46,988 shares during the period. Rhumbline Advisers boosted its stake in Aspen Aerogels by 13.7% in the 2nd quarter. Rhumbline Advisers now owns 93,226 shares of the construction company's stock worth $2,223,000 after purchasing an additional 11,205 shares during the period. Victory Capital Management Inc. acquired a new position in Aspen Aerogels in the 2nd quarter worth approximately $230,000. American Century Companies Inc. grew its position in Aspen Aerogels by 562.3% during the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company's stock worth $18,382,000 after purchasing an additional 654,350 shares in the last quarter. Finally, O Neil Global Advisors Inc. acquired a new stake in Aspen Aerogels during the 2nd quarter valued at $506,000. Institutional investors own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.